WS Management’s DexCom DXCM Stock Holding History

WS Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,949	Closed	-$133K	–	43
2025 Q1	$133K	Buy	+1,949	New	+$159K	0.01%	45
2023 Q4	–	Sell	-261,604	Closed	-$26.7M	–	72
2023 Q3	$24.4M	Buy	+261,604	New	+$29.5M	1.97%	15
2023 Q2	–	Sell	-100	Closed	-$12.1K	–	67
2023 Q1	$11.6K	Buy	+100	New	+$11.2K	﹤0.01%	60

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

WS Management's DXCM Position: Q2 2025 in Review

WS Management sold out of DexCom (DXCM) in Q2 2025, closing a stake of 1,949 shares — an estimated $133K sold.

WS Management first reported a position in DXCM in Q1 2023 and held it in 3 quarters. The position peaked at $24.4M in Q3 2023. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

WS Management reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
WS Management sold 1,949 DexCom shares in Q2 2025, an estimated $133K.
WS Management first reported a position in DexCom in Q1 2023 and held it in 3 quarters.
WS Management's DexCom position peaked at $24.4M in Q3 2023.
939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on WS Management's 13F filing for Q2 2025, filed 14 Aug 2025.